Ravija Singh is a highly experienced professional in the pharmaceutical and biotechnology sectors, currently serving as a Principal Specialist at Boehringer Ingelheim since March 2014 and previously held the position of Senior Scientist within the same firm. Prior to this, Ravija worked at AbbVie as a Scientist I from May 2011 to December 2014 and gained early career experience as a Process Development Associate at Perseid Therapeutics in 2011. Earlier roles include Development Associate at PDL BioPharma from October 2003 to May 2008 and Research Associate at Aclara Biosciences from August 2000 to April 2001. Ravija holds a Master of Science degree in Chemistry from San Jose State University.